Stone
J.A.:
—
This
is
an
appeal
from
a
judgment
of
the
Tax
Court
of
Canada
of
July
17,
1995
dismissing
an
appeal
from
a
reassessment
by
the
Minister
of
National
Revenue
in
respect
of
the
Appellant’s
income
for
its
1986
taxation
year.
The
background
of
the
dispute
is
outlined
in
the
reasons
for
judgment
of
the
learned
Tax
Court
Judge.
As
those
reasons
are
now
fully
reported
in
MDS
Health
Group
Ltd.
v.
R.,
(sub
nom.
MDS
Health
Group
Ltd.
v.
Canada)
[1995]
2
C.T.C.
2526,
96
D.T.C.
1324,
it
is
not
necessary
to
restate
the
facts
in
detail
here.
The
central
issue
is
whether
an
amount
received
by
the
Appellant
in
November
1986
from
a
partnership
formed
by
the
Appellant
and
its
copartner
in
October
1986
was
properly
assessed
by
the
Minister
on
the
basis
that
it
was
consideration
for
transferring
certain
technology
to
the
partnership
in
excess
of
the
nominal
amount
elected
by
the
parties
pursuant
to
subsection
97(2)
of
the
Income
Tax
Act
R.S.C.
1952,
c.
148,
as
amended
,
and,
accordingly,
that
one-half
of
the
excess
was
required
to
be
included
in
income
as
an
eligible
capital
amount
by
virtue
of
paragraph
85(1
)(b)
and
subsection
14(1)
of
that
statute.
The
fundamental
position
of
the
Appellant
both
here
and
below
was
that
the
amount
received
-
$1,500,000
(U.S.)
-
cannot
be
viewed
as
consideration
in
excess
of
the
amount
elected
as
consideration
for
the
technology
transferred
to
the
partnership.
That
argument
was
based
on
viva
voce
and
other
evidence
of
the
arrangement
contemplated
by
the
parties
to
the
partnership
agreement
and
on
various
provisions
of
the
agreement
itself
as
showing
that
the
Appellant
had
accepted
to
be
bound
by
a
legal
obligation
to
recontribute
the
amount
withdrawn.
It
was
on
this
basis
that
the
Appellant
sought
to
distinguish
the
decision
of
Reed
J.
in
Haro
Pacific
Enterprises
Ltd.
v.
R.,
(sub
nom.
Haro
Pacific
Enterprises
Ltd.
v.
Canada)
[1990]
2
C.T.C.
493,
90
D.T.C.
6583
(F.C.T.D.).
The
Appellant’s
argument
was
rejected
by
the
Tax
Court
Judge,
who
stated
at
pages
11-12
of
this
reasons:
Although
the
issues
have
been
ably
argued
by
both
counsel
for
the
Appellant,
I
have
concluded
that
the
submissions
of
the
Respondent
better
reflect
the
true
nature
of
the
transaction.
In
the
first
place,
there
is
no
indication
in
the
partnership
agreement
that
the
$1,500,000
(U.S.)
withdrawn
must
be
recontributed.
Secondly,
the
continuing
obligation
to
inject
$1,500,000
(U.S.)
by
each
partner
over
a
period
of
three
years,
in
my
opinion,
simply
relates
to
the
additional
funding
which
each
party
was
obliged
to
make
to
pay
for
the
costs
of
research
and
development.
Note
that
section
4.2
of
the
partnership
agreement
refers
to
“Initial
Contributions”
referring
to
$1,500,000
(U.S.)
and
the
technology
and
section
4.5
refers
to
“Sustaining
Contributions”.
Nothing
in
the
partnership
agreement
connects
the
$1,500,000
(U.S.)
withdrawn
by
MDS
to
the
“Sustaining
Contributions”.
Thirdly,
there
are
no
accounting
records
of
any
entity
showing
the
liability
or
obligation
of
MDS
to
recontribute
the
$1,500,000
(U.S.).
This
amount
may
not
have
been
material
for
MDS
but
it
was
so
for
the
partnership.
Fourthly,
in
fact
the
additional
contributions
made
by
each
partner
show
no
correlation
to
the
$1,500,000
(U.S.)
withdrawn.
For
example,
the
amounts
contributed
were
not
3
x
$500,000
(U.S.)
for
each
partner
but
rather
were
instalments
contributed
from
time
to
time
in
differing
amounts,
totalling
more
than
$1,500,000
(U.S.)
for
each
partner.
Fifthly,
although
the
lengthy
testimony
given
by
Wilfred
G.
Lewitt
was
credible,
in
the
most
important
aspect
of
this
case
-
1.e.,
the
alleged
obligation
to
recontribute
the
$1,500,000
(U.S.)
withdrawn,
neither
the
terms
of
the
partnership
agreement
nor
the
subsequent
contributions
in
varying
amounts,
support
his
interpretation.
The
letter
of
July
11,
1986
to
Canadian
Patents
&
Development
Limited
is
not
persuasive
and
moreover
is
not
reflected
in
the
partnership
agreement.
Sixthly,
the
expert
accounting
evidence,
if
anything,
indicates
that
in
the
year
in
question
(1986)
the
most
acceptable
treatment
of
a
transfer
of
technology
to
a
partnership
was
a
recognition
of
a
gain
by
the
transferring
partner.
The
Appellant
contends
that
each
of
these
findings
and
conclusions
of
the
Tax
Court
Judge
is
erroneous.
Counsel
emphasized
in
particular
that
the
Tax
Court
Judge
ought
to
have
had
regard
for
the
viva
voce
and
other
evidence
which
was
lead
by
the
Appellant
as
showing
that
from
the
outset
it
was
contemplated
that
the
Appellant
as
a
partner
would
be
entitled
to
do
what
it
actually
did,
namely
withdraw
the
amount
in
issue
temporarily
and
recontribute
it
to
the
partnership
during
the
first
three
fiscal
years
of
the
partnership
in
accordance
with
clause
4.5
of
the
partnership
agreement.
While
it
is
plain
that
the
Tax
Court
Judge
did
find
the
evidence
of
the
principal
witness
“credible”
to
the
extent
indicated,
he
also
found
that
“neither
the
terms
of
the
agreement
nor
the
subsequent
contributions
in
varying
amounts,
support
his
interpretation”.
It
seems
to
us
that
the
Tax
Court
Judge
was
there
performing
his
normal
function
of
assessing
and
weighing
the
evidence
and
that
in
the
end
he
did
not
accept
the
evidence
in
question
as
reflecting
the
true
nature
of
the
transaction.
As
was
pointed
out
by
La
Forest
J.
in
Schwartz
v.
R.,
(sub
nom.
Schwartz
v.
Canada)
[1996]
1
S.C.R.
254,
[1996]
1
C.T.C.
303,
96
D.T.C.
6103,
at
page
278
(C.T.C.
319),
“...appellate
courts
must
treat
a
trial
judge’s
findings
of
fact
with
great
deference”
and,
as
appears
in
the
passage
recited
at
the
same
page
from
the
judgement
of
Lord
Shaw
in
Clarke
v.
Edinburgh
and
District
Tramways
Co.,
[1919]
S.C.
(H.L.)
35,
56
S.L.R.
303,
at
pages
36-37
and
from
the
other
authorities
there
cited
by
La
Forest
J.,
this
deference
extends
to
the
weight
given
to
the
evidence
by
a
trial
judge.
Nor
are
we
persuaded
that
the
Tax
Court
Judge
misconstrued
the
relevant
provisions
of
the
partnership
agreement
by
concluding
that
it
contained
“no
indication...that
the
$1,500,000
(U.S.)
withdrawn
must
be
recontributed”
and
that
there
was
no
nexus
between
the
obligation
of
the
Appellant
and
its
co-partner
to
make
the
above
referred
to
capital
contributions
of
$500,000
(U.S.)
during
each
of
the
first
three
fiscal
years
pursuant
to
clause
4.5
and
the
withdrawal
of
the
$1,500,000
(U.S.)
amount
as
an
“initial
contribution
by
way
of
return
of
capital”
pursuant
to
clause
11.2
of
the
partnership
agreement.
We
respectfully
agree
with
the
Tax
Court
Judge
that
nothing
in
the
language
of
clause
4.5
or
in
any
other
provision
of
the
agreement
imposed
upon
the
Appellant
an
obligation
to
recontribute
the
withdrawn
amount
as
such.
The
appeal
will
be
dismissed
with
costs.
Appeal
dismissed.